The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
Voting is now open for the 2024 Company of the Year Awards
137 search results
After a madcap back and forth between leading and dissenting Democrats, Biden’s drug pricing reform plans have reached a compromised final form.
In a market filled with complexity, working with a single supplier simplifies the supply chain and focuses effort towards a single target.
Researchers at Trinity College Dublin explain how they are reaching into the natural environment to source new bioactives.
The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.
Part 2 of our roundtable discussion with CDMOs covers outsourcing preferences, the demand for mRNA, and more.
What lessons were learned from Operation Warp Speed?
The pharma industry is one of the biggest targets for cybercrime. How can companies avoid succumbing to attack?
Defining the best strategies for working with highly potent drug substances.
What milestones will define the next era in the mRNA story?
Manufacturers must look to ease the headaches associated with the manufacture of mRNA-based products.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
Meet an AI Model that Predicts Teratogenicity
FDA Approves First OTC Contraceptive
Feeling the Heat